Therapeutic of Candesartan and Music Therapy in Diabetic Retinopathy with Depression in Rats

Therapeutic of Candesartan and Music Therapy in Diabetic Retinopathy with Depression in Rats

This study aimed to investigate the therapeutic effects of candesartan combined with music therapy on diabetic retinopathy with depression and to assess the molecular mechanisms. Associated animal model of diabetes mellitus and depression was established in rats. Pathological changes in the hippocam...

Full description

Bibliographic Details
Main Authors:	Chengping Luo, Huimin Fan, Shaojun Li, Yuling Zou
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Evidence-Based Complementary and Alternative Medicine
Online Access:	http://dx.doi.org/10.1155/2021/5570356

Similar Items

The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics
Published: (2005-03-01)

The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design
by: Nish Chaturvedi
Published: (2002-12-01)

DIRECT. Results of the study on effectiveness of candesartan (angiotensin II receptor antaginist) in prevention of diabetes retinopathy progression
by: Editorial team Diabetes Mellitus
Published: (2008-09-01)

Therapeutic effect and mechanism of paclitaxel on diabetic retinopathy model rats
by: Dan Guo, et al.
Published: (2019-12-01)

Beneficial Effect of Candesartan on Rat Diastolic Heart Failure
by: Ryotaro Wake, et al.
Published: (2005-01-01)

Candesartan Normalizes Changes in Retinal Blood Flow and p22phox in the Diabetic Rat Retina
by: Randa S. Eshaq, et al.
Published: (2021-03-01)

CANDESARTAN IN CARDIOLOGY PRACTICE
by: N. A. Dzhaiani
Published: (2017-12-01)

Candesartan in treating hypertension
by: L O Minushkina
Published: (2014-03-01)

Candesartan in nephrological practice
by: Ya.A. Dombrovskyi, et al.
Published: (2014-02-01)

Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy
by: O L Barbarash, et al.
Published: (2013-12-01)

Depression and Music Therapy: A New Therapeutic Method
by: Mausner, Oliver
Published: (2017)

Review of therapeutic advances in diabetic retinopathy
by: Carolyn Chen, et al.
Published: (2011-02-01)

Biomarkers in Diabetic Retinopathy and the Therapeutic Implications
by: Katarzyna Zorena, et al.
Published: (2013-01-01)

Prevalence of Depression in Patients with Diabetic Retinopathy
by: Nooshin Bazzazi, et al.
Published: (2021-03-01)

The Effect of Chronic Candesartan Therapy on the Metabolic Profile and Renal Tissue Cytokine Levels in the Obese Zucker Rat
by: Carolyn M. Ecelbarger, et al.
Published: (2010-01-01)

Biorelevant dissolution of candesartan cilexetil
by: Lucie Gruberová, et al.
Published: (2017-03-01)

Reversal of cardiovascular remodelling with candesartan
by: Lindsay Brown, et al.
Published: (2001-03-01)

Candesartan cilexetil in cardiovascular prevention
by: A. Ya. Ivleva
Published: (2007-12-01)

Formulation and Bioavailability of Novel Mucoadhesive Buccal Films for Candesartan Cilexetil in Rats
by: Omar Y. Mady, et al.
Published: (2021-08-01)

Neurodegeneration in Diabetic Retinopathy: Current Concepts and Therapeutic Implications
by: Ning-Li Wang
Published: (2016-01-01)

Effect of melatonin on diabetic retinopathy in rats
by: Hui-Jie Diao, et al.
Published: (2019-10-01)

Adult Stem Cell Therapeutics in Diabetic Retinopathy
by: Sriprachodaya Gaddam, et al.
Published: (2019-09-01)

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
by: Cristina Hernández, et al.
Published: (2016-01-01)

ROCK as a Therapeutic Target of Diabetic Retinopathy
by: Ryoichi Arita, et al.
Published: (2010-01-01)

Therapeutic potential of Juglans regia L. leaf extract against diabetic retinopathy in rat
by: Davood Nasiry, et al.
Published: (2017-11-01)

Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients
by: Ashcheulova Tatiana, et al.
Published: (2018-12-01)

Clinical research on laser therapy and Ranibizumab for proliferative diabetic retinopathy
by: Hong Zou, et al.
Published: (2016-01-01)

Effects of Shuangdanmingmu capsule on blood glucose and retinopathy in rats with diabetic retinopathy
by: Yu-Hui Qin, et al.
Published: (2014-11-01)

The effects of angiotensin II receptor antagonist (candesartan) on rat renal vascular resistance
by: Supatraviwat, J, et al.
Published: (2004-05-01)

Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat
by: Kuldeep Singh Thakur, et al.
Published: (2015-12-01)

Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
by: Karin Skov, et al.
Published: (2001-03-01)

Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study
by: JP Baguet, et al.
Published: (2009-01-01)

The Safety and Tolerability of Candesartan Cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01)

The safety and tolerability of candesartan cilexetil in CHF
by: Erland Erdmann, et al.
Published: (2000-03-01)

Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
by: Michael Whitehead, et al.
Published: (2019-01-01)

Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
by: Amna Parveen, et al.
Published: (2018-06-01)

Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics
by: Agarwal A, et al.
Published: (2014-12-01)

DYNAMICS OF PARAMETERS OF PROINFLAMMATORY ACTIVATION IN PATIENTS WITH HYPERTENSION UNDER INFLUENCE OF CANDESARTAN THERAPY
by: V. A. Vizir, et al.
Published: (2014-05-01)

Anti-Inflammatory Therapy in Diabetic Retinopathy
by: Katarzyna Zorena
Published: (2014-01-01)

Proteomics identifies new potential therapeutic targets of diabetic retinopathy
by: Hu, Y., et al.
Published: (2022)